Exact Sciences Corp. [NASDAQ: EXAS] stock went on a downward path that fall over -7.04% on Thursday, amounting to a one-week price decrease of less than -7.39%. Over the last 12 months, EXAS stock dropped by -7.49%. The one-year Exact Sciences Corp. stock forecast points
Exact Sciences Corp. [NASDAQ: EXAS] price plunged by -0.88 percent to reach at -$0.65. The company report on April 11, 2024 at 6:00 AM that Exact Sciences Announces Debt Exchange Transaction and Private Placement of Convertible Senior Notes. Exact Sciences Corp. (Nasdaq: EXAS) (the “Company”),
Exact Sciences Corp. [NASDAQ: EXAS] traded at a high on Tuesday, posting a 4.73 gain after which it closed the day’ session at $73.74. The company report on March 28, 2024 at 6:00 AM that Exact Sciences Advances Development of Non-Endoscopic Oncoguard® Esophagus Test to
Exact Sciences Corp. [NASDAQ: EXAS] loss -1.05% or -0.66 points to close at $62.00 with a heavy trading volume of 3974006 shares. The company report on March 13, 2024 at 5:03 PM that The New England Journal of Medicine Publishes Cologuard Plus™ Test Results from
Exact Sciences Corp. [NASDAQ: EXAS] stock went on a downward path that fall over -6.00% on Thursday, amounting to a one-week price decrease of less than -4.19%. The company report on February 21, 2024 at 4:05 PM that Exact Sciences Announces Fourth Quarter 2023 Results.
© 2024, Powered by Smart TechOne
